Therapeutic Plasma Exchange in Severe Thyrotoxicosis: Clinical Observations From a Case Series
- 20 January 2026
- journal article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 111 (5) , e1273-e1280
Abstract
Context: Severe thyrotoxicosis and thyroid storm have a high morbidity and mortality risk and are commonly managed with antithyroid drugs. In some patients, a combination therapy with medications and thyroidectomy as definite treatment are required. Therapeutic Plasma Exchange (TPE) can be used as a temporizing measure to achieve thyroid hormone normalization and to prevent perioperative complications before surgery. Objective: We describe 6 cases of severe thyrotoxicosis and/or thyroid storm who underwent TPE as a bridge to thyroidectomy and present the clinical characteristics and outcomes. We aim to propose a preoperative thyroid hormone target. Methods: We collected data of 6 patients who were diagnosed with severe thyrotoxicosis or thyroid storm between April 2023 and April 2024 and that were treated with TPE due to high mortality risk or refractoriness to medical treatment. Data collected included the baseline clinical characteristics, laboratory data, clinical progress, and outcomes. Thyroid hormone levels at diagnosis, before initiation of TPE, and before thyroidectomy were compared using statistical analysis. Results: Four of 6 patients underwent thyroidectomy, and 2 patients died due to multiorgan dysfunction. The mean free T4 (fT4) level at diagnosis was 4.8 ng/dL (reference range, 0.8-1.8 ng/dL), 5.4 ng/dL pre-TPE, and 2.6 ng/dL prethyroidectomy, resulting in a mean difference of 2.8 ng/dL (51.7%) reduction (95% CI, 1.1-4.5; P = .01). The number of TPE treatments to reach a preoperative fT4 level of 2.5 ng/dL was 5.5 treatments (P = .03). Conclusion: These results reflect efficacy of TPE as a bridge to thyroidectomy and suggest that a preoperative fT4 goal of 2.5 to 3.3 can be considered in patients with severe thyrotoxicosis and thyroid storm that are refractory to medical treatment.Keywords
This publication has 31 references indexed in Scilit:
- Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special IssueJournal of Clinical Apheresis, 2023
- Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosisThe Lancet Diabetes & Endocrinology, 2023
- Efficacy of preoperative therapeutic plasma exchange in patients with hyperthyroidism and factors affecting the number of sessionsEndocrine, 2022
- Outcomes After Urgent Thyroidectomy Following Rapid Control of Thyrotoxicosis in Graves’ Disease are Similar to Those After Elective Surgery in Well‐Controlled DiseaseWorld Journal of Surgery, 2019
- Therapeutic plasmapheresis in thyrotoxic patientsEndocrine, 2018
- Hyperthyroidism and Risk of Atrial Fibrillation or FlutterArchives of internal medicine (1960), 2004
- Liver transplantation for acute liver failure from drug induced liver injury in the United StatesLiver Transplantation, 2004
- Cardiovascular manifestations of thyroid storm: a case reportThe Journal of Emergency Medicine, 2003
- Life-Threatening Thyrotoxicosis: Thyroid StormEndocrinology and Metabolism Clinics of North America, 1993
- Thyroid crisis presenting as comaClinical Neurology and Neurosurgery, 1984